Federated Hermes’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Federated Hermes’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-28,196	Closed	-$994K	–	2167
2015 Q1	$994K	Buy	28,196 +3,010	+12%	+$102K	﹤0.01%	1180
2014 Q4	$809K	Buy	25,186 +4,420	+21%	+$128K	﹤0.01%	1242
2014 Q3	$583K	Buy	20,766 +1,096	+6%	+$33.4K	﹤0.01%	1316
2014 Q2	$594K	Sell	19,670 -249	-1%	-$6.87K	﹤0.01%	1315
2014 Q1	$551K	Sell	19,919 -5,436	-21%	-$142K	﹤0.01%	1323
2013 Q4	$648K	Buy	25,355 +7,021	+38%	+$216K	﹤0.01%	1262
2013 Q3	$548K	Sell	18,334 -1,911	-9%	-$53.1K	﹤0.01%	1283
2013 Q2	$582K	Buy	+20,245	New	+$558K	﹤0.01%	1248

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Federated Hermes's BRLI Position: Q2 2015 in Review

Federated Hermes sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 28,196 shares — an estimated $994K sold.

Federated Hermes first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $994K in Q1 2015. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

Federated Hermes reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
Federated Hermes sold 28,196 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $994K.
Federated Hermes first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
Federated Hermes's BIO-REFERENCE LABS INC-NEW- position peaked at $994K in Q1 2015.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Federated Hermes's 13F filing for Q2 2015, filed 12 Aug 2015.